It has been informed by MeitY that they will continue to do the routine surveillance of the products covered under CRS and have advised.
As advised by MeitY, the surveillance of the products under their purview has been kept in abeyance. However, since BIS had already initiated the process of drawl of samples, the same was completed. The samples of a few consumer items were drawn which are being tested in BIS recognized laboratories.
The concerned licensees will have to pay the sample cost, testing charges as well as the overhead in accordance the provisions laid down in BIS Conformity Assessment Regulations 2018 and the approved guidelines. The details will be shared with the concerned licensees in due course.
The DDs of the licensees who paid the surveillance cost will be returned to them in case their samples have not been drawn.